Sea4Us
Private Company
Total funding raised: $3.3M
Overview
Sea4Us is a private, pre-revenue biotech leveraging Portugal's marine biodiversity to build a pipeline of novel small molecule drugs. The company employs a marine discovery platform, isolating and characterizing bioactive compounds from deep-sea organisms for therapeutic applications. While specific pipeline details are not publicly disclosed on the homepage, the company's focus is on translating marine-derived leads into treatments for significant unmet medical needs. It appears to be in a pre-clinical or discovery stage, supported by partnerships, crowdfunding, and EU co-funding.
Technology Platform
Integrated marine biodiscovery platform for isolating and characterizing novel bioactive small molecules from deep-sea organisms.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes with other marine biotechs (e.g., PharmaMar, Australian institutes) and broader natural product discovery companies. Differentiation lies in focus on specific Atlantic deep-sea ecosystems and integrated in-house labs from collection to physiology.